OCT Location

Emerging markets such as Central and Eastern Europe have become widely accepted by the biopharmaceutical industry as ideal locations for conducting clinical trials due to their high enrollment rates, unparalleled access to untapped patient populations, experienced investigators and centralized healthcare systems. Having proved itself as a leading CRO in CEE, OCT has started operations in the US.

OCT’s footprint includes the following countries:

  • Russia
  • Ukraine
  • Belarus
  • Latvia
  • Estonia
  • Lithuania
  • Bulgaria
  • Georgia
  • USA

OCT are not limited to the above listed countries and have well developed networks and connections with several leading Western European CROs. All this enables us to perform studies in any region (if required).